(TheNewswire)
Tampa, FL. - TheNewswire - July 15, 2024 – CTT Pharmaceuticals Holdings, Inc. (OTC: CTTH), is pleased to announce a contract has been signed with a PCAOB accountant. CTT will move forward immediately with a PCAOB audit of the Company's Financial Statements for 2023 and 2022. The Accounting firm that is conducting this audit is registered with the Public Company Accounting Oversight Board(PCAOB) and will be done within the guidelines of Generally Accepted Accounting Principles (GAAP) and according to the standards and practices for audits of public companies ascribed by the Public Company Accounting Oversight Board (PCAOB). CTT Pharma anticipates this audit should be completed in the next 2-3 weeks and will issue a news release to shareholders upon the completion of this audit.
The Public Company Accounting Oversight Board protects investors and other stakeholders of public companies by ensuring that the auditor of a company’s financial statements has followed a set of strict guidelines to minimize audit risk. The PCAOB is a non-profit organization that regulates auditors of publicly traded companies and oversees the audits of public companies, brokers, and dealers registered with the U.S. Securities and Exchange Commission (SEC).
Ryan Khouri, CEO of CTT Pharma, stated, “This is a necessary step for giving additional transparency of CTT's financial statements to existing shareholders, new shareholders, companies that are looking to partner with CTT Pharma and the U.S. Government. Furthermore, this PCAOB audit will allow CTT Pharma the ability to uplist to a higher tier, allow mergers and acquisitions, and potentially bring more liquidity to CTT. Personally, I’d like to see CTT Pharma uplist in the near future and will make that decision based upon the outcome of multiple events.”
About CTT Pharmaceuticals Holdings, Inc.
CTT has granted and pending patents for our technology in the United States, Europe, Canada and several other countries around the world to allow for many drugs to be put on dissolvable strips and other oral products, including but not limited to Pharmaceuticals, Nicotine, Liraglutide, Vitamins, and Caffeine. This patented technology allows for better bioavailability/absorption, quick onset, and the ability to make low dose dissolvable strips.
Company Info:
Phone: 813-606-0060
Twitter/X: @CTT_Pharma
Copyright (c) 2024 TheNewswire - All rights reserved.